亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Reply: Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis

脂肪肝 医学 胃肠病学 内科学 荟萃分析 酒精性肝病 肝纤维化 疾病 纤维化 病理 肝硬化
作者
Andrea Dalbeni,Alessandro Mantovani,Rosa Lombardi,Federico Ravaioli
出处
期刊:Hepatology [Wiley]
卷期号:79 (5): E146-E147 被引量:1
标识
DOI:10.1097/hep.0000000000000721
摘要

We would like to thank Hui Liu et al1 for their interest in our systematic review and meta-analysis aiming to evaluate the diagnostic accuracy of the AGILE3+ score for detecting advanced fibrosis in patients with NAFLD.2 The issues raised by the authors merit to be addressed. First, regarding the potential use of the term "MASLD" (metabolic dysfunction-associated steatotic liver disease) for our systematic research, it is important to note that we systematically searched MEDLINE, Ovid Embase, Scopus, and Cochrane Library electronic databases from the inception to the 24th of April 2023. Consequently, it was not possible to conduct systematic research using the keyword "MASLD" as articles related to this new classification were published later. Second, it is worth acknowledging that the term "MAFLD" (metabolic dysfunction-associated fatty liver disease) has not been exclusively utilized as a keyword in any article discussing the diagnostic accuracy of the AGILE3+ score until April 2023. Indeed, Hui Liu et al should have recognized that the main cohort of study by Tang et al3 was originally included in our meta-analysis,2 while the validation cohort from that paper was effectively not included. During the process of data extraction and quality assessment, Federico Ravaioli, Andrea Dalbeni, and Alessandro Mantovani discussed the decision only to include data from the derivation cohort. The reason for this decision was twofold: first, the derivation cohort was larger than the validation cohort; second, a conservative approach was preferred due to the cutoffs used for the rule-in and rule-out. We acknowledge that this approach may be open to criticism. Therefore, to be definitive, we conducted subanalyses and sensitivity analyses that strongly suggest the accuracy of the AGILE3+ score in detecting advanced fibrosis in patients with liver disease. Moreover, we would like to clarify that the validation cohort in the study by Tang et al consisted of 142 patients, not 132, as disputed by the authors.3 Third, given that the study by Noereddin et al4 was fully published after our research, it was not reasonable to include it in our systematic review and meta-analysis. Fourth, with respect to the absence of a meta-analysis conducted on the AGILE 4 score, we would like to point out that this was not the aim of the present study. However, we encourage the authors to contemplate this aim for their next article if they believe it would be beneficial and pertinent to the scientific community. Fifth, regarding the typos observed in the graphic abstract, we would like to remind the authors that they have read a pre-edited draft and that we had already corrected the typos during the proofreading process. Before expressing any judgment, it is always best to wait for the final edited version since it is specified and known that pre-proofs could contain some typos. Unfortunately, we should all keep in mind that the Dunning-Kruger effect is always around the corner. Finally, we disagree with the authors,3 who proposed performing a network meta-analysis to improve the current meta-analysis on the AGILE3+score for detecting advanced fibrosis. The only viable option to enhance the current meta-analysis is conducting an individual patient meta-analysis, as stated in the manuscript. Nevertheless, to dispel any doubts, we have repeated the analysis, including the validation cohort of the study by Tang et al3 and the study by Noureddin et al4: by the rule-out cutoff, the overall sensitivity and specificity were 85% (95% CI: 74%–92%; I2=97%) and 58% (95% CI: 46%–70%; I2=98%), respectively; by the rule-in cutoff, the overall sensitivity and specificity were 69% (95% CI: 59%–78%; I2=90%) and 86% (95% CI: 80%–91%; I2=97%), respectively. In conclusion, our rigorous meta-analysis of over 7600 patients with biopsy-confirmed NAFLD, including 690 newly added patients, reaffirms the validity and accuracy of the AGILE3+ score as a diagnostic tool for NAFLD with advanced fibrosis. These results are significant, as they provide clear evidence that the AGILE3+ score can be used effectively in clinical practice to identify patients who may require biopsy and emerging pharmacotherapies. The conclusions of paper2 are accurate, and our findings underline the importance of utilizing the AGILE3+ score in diagnosing NAFLD with advanced fibrosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小酸应助平淡青筠采纳,获得10
12秒前
13秒前
18秒前
27秒前
传奇3应助科研通管家采纳,获得10
41秒前
1分钟前
直率铁身完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
2分钟前
Talha完成签到,获得积分10
2分钟前
充电宝应助Frankyu采纳,获得10
2分钟前
2分钟前
晴天向日葵完成签到,获得积分10
2分钟前
2分钟前
2分钟前
Frankyu发布了新的文献求助10
2分钟前
2分钟前
3分钟前
bao完成签到,获得积分10
3分钟前
思源应助Makta采纳,获得10
3分钟前
Qvby3完成签到 ,获得积分10
3分钟前
3分钟前
jasonjiang完成签到 ,获得积分10
4分钟前
Makta发布了新的文献求助10
4分钟前
4分钟前
852应助mingyue采纳,获得10
4分钟前
Makta完成签到,获得积分10
4分钟前
4分钟前
4分钟前
4分钟前
4分钟前
5分钟前
6分钟前
爆米花应助冯乾采纳,获得10
6分钟前
百发百中发布了新的文献求助10
6分钟前
6分钟前
冯乾发布了新的文献求助10
6分钟前
百发百中完成签到,获得积分10
6分钟前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 600
The Conscience of the Party: Hu Yaobang, China’s Communist Reformer 600
MATLAB在传热学例题中的应用 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3303242
求助须知:如何正确求助?哪些是违规求助? 2937578
关于积分的说明 8482477
捐赠科研通 2611463
什么是DOI,文献DOI怎么找? 1425919
科研通“疑难数据库(出版商)”最低求助积分说明 662457
邀请新用户注册赠送积分活动 647005